Replies to post #21580 on Elite Pharmaceuticals Inc (ELTP)

[ivorytowerboy]

My business guru friends... As you probably know, NASDAQ has recently lowered its qualifications for listing.

http://www.redchip.com/blog/index.php/uncategorized/sec-approves-alternative-nasdaq-listing-requirements/

Given the following scenario, would it be possible for ELTP to become NASDAQ eligible in 18 months after product launch?

The scenario: ELTP is approved for the manufacture of abuse-resistant hydrocodone which has a $300M a year market. ELTP succeeds in capturing an average of 20% of the market over 6 quarters (i.e., $90M in total revenue over 18 months)

[richme]

JT and Elite also use a disclaimer large enough to allow the largest aircraft careers to thus making the CC a statement of intent rather than a contract to carryout the intent. It is not new, most companies use the disclaimer. It is likely that the plans in CCs and press releases are more a statement of intent than a plan of action. There are issues that were announced perhaps a cut above planned that never materialized, Socius loan being one of them and it dropped because as stated in the disclaimer; the essence, we will do our best but don't hold us to it.

[richme]

More specifically my comments addressed the possibility that Elite's funds for Phase 3 would come from a Socius type deal; if I recall the Socius deal would add about 70M common shares. Thus my comments suggested that if Elite continues issuing shares it would be dilutive and in time could lead to a reverse split. It was no more or no less but it got out of hand in the response stage. Now if I had written that Elite or ELTP's PPS would in some way head for the sky that would have been very positive or at least judging from past posts on this board. Hope that helps.